Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 2007, 57: 43-66.
PubMed
Google Scholar
Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983, 15: 10-7. 10.1016/0090-8258(83)90111-7.
CAS
PubMed
Google Scholar
Sherman ME: Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000, 13: 295-308. 10.1038/modpathol.3880051.
CAS
PubMed
Google Scholar
Lax SF, Kurman RJ: A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol. 1997, 81: 228-32.
CAS
PubMed
Google Scholar
Liu FS: Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol. 2007, 46: 26-32.
CAS
PubMed
Google Scholar
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J: Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol. 2001, 32: 569-77. 10.1053/hupa.2001.25929.
CAS
PubMed
Google Scholar
Lax SF: Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 2004, 444: 213-23. 10.1007/s00428-003-0947-3.
CAS
PubMed
Google Scholar
Deligdisch L, Holinka CF: Endometrial carcinoma: two diseases?. Cancer Detect Prev. 1987, 10: 237-46.
CAS
PubMed
Google Scholar
Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR: Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst. 1996, 88: 1127-35. 10.1093/jnci/88.16.1127.
CAS
PubMed
Google Scholar
Shang Y: Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer. 2006, 6: 360-8. 10.1038/nrc1879.
CAS
PubMed
Google Scholar
Ettinger B, Golditch IM, Friedman G: Gynecologic consequences of long-term, unopposed estrogen replacement therapy. Maturitas. 1988, 10: 271-82. 10.1016/0378-5122(88)90063-1.
CAS
PubMed
Google Scholar
Gambrell RD: Estrogens, progestogens and endometrial cancer. J Reprod Med. 1977, 18: 301-6.
PubMed
Google Scholar
Demopoulos RI, Mesia AF, Mittal K, Vamvakas E: Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis. Int J Gynecol Pathol. 1999, 18: 233-7.
CAS
PubMed
Google Scholar
Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW: Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol. 2000, 13: 379-88. 10.1038/modpathol.3880062.
CAS
PubMed
Google Scholar
Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S: Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003, 83 (Suppl 1): 79-118. 10.1016/S0020-7292(03)90116-0.
PubMed
Google Scholar
Mutter GL: Pten, a protean tumor suppressor. Am J Pathol. 2001, 158: 1895-1898.
PubMed Central
CAS
PubMed
Google Scholar
Konopka B, Janiec-Jankowska A, Czapczak D, Paszko Z, Bidzinski M, Olszewski W, Goluda C: Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations. J Cancer Res Clin Oncol. 2007, 133: 361-71. 10.1007/s00432-006-0179-4.
CAS
PubMed
Google Scholar
Risinger JI, Hayes AK, Berchuck A, Barrett JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 1997, 57: 4736-8.
CAS
PubMed
Google Scholar
Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 1997, 57: 3935-40.
CAS
PubMed
Google Scholar
Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG: MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 1998, 17: 2413-2417. 10.1038/sj.onc.1202178.
CAS
PubMed
Google Scholar
Faquin WC, Fitzgerald JT, Boynton KA, Mutter GL: Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas. Gynecol Oncol. 2000, 78: 152-157. 10.1006/gyno.2000.5858.
CAS
PubMed
Google Scholar
Velasco A, Bussaglia E, Pallares J, Dolcet X, Llobet D, Encinas M, Llecha N, Palacios J, Prat J, Matias-Guiu X: PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. Hum Pathol. 2006, 37: 1465-72. 10.1016/j.humpath.2006.05.007.
CAS
PubMed
Google Scholar
Sasano H, Comerford J, Wilkinson DS, Schwartz A, Garrett CT: Serous papillary adenocarcinoma of the endometrium. Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry. Cancer. 1990, 65: 1545-51. 10.1002/1097-0142(19900401)65:7<1545::AID-CNCR2820650716>3.0.CO;2-8.
CAS
PubMed
Google Scholar
Lax SF, Pizer ES, Ronnett BM, Kurman RJ: Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol. 1998, 29: 551-8. 10.1016/S0046-8177(98)80002-6.
CAS
PubMed
Google Scholar
Nordstrom B, Strang P, Lindgren A, Bergstrom R, Tribukait B: Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression. Anticancer Res. 1996, 16: 899-904.
CAS
PubMed
Google Scholar
Sherman ME, Bur ME, Kurman RJ: p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum Pathol. 1995, 26: 1268-1274. 10.1016/0046-8177(95)90204-X.
CAS
PubMed
Google Scholar
Halperin R, Zehavi S, Habler L, Hadas E, Bukovsky I, Schneider D: Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium. Eur J Gynaecol Oncol. 2001, 22: 122-6.
CAS
PubMed
Google Scholar
Rolitsky CD, Theil KS, McGaughy VR, Copeland LJ, Niemann TH: HER-2/neu amplification and overexpression in endometrial carcinoma. Int J Gynecol Pathol. 1999, 18: 138-43.
CAS
PubMed
Google Scholar
Lauchlan SC: Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med. 1981, 105: 615-8.
CAS
PubMed
Google Scholar
Eifel PJ, Ross J, Hendrickson M, Cox RS, Kempson R, Martinez A: Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons. Cancer. 1983, 52: 1026-31. 10.1002/1097-0142(19830915)52:6<1026::AID-CNCR2820520617>3.0.CO;2-3.
CAS
PubMed
Google Scholar
Lee KR, Belinson JL: Papillary serous adenocarcinoma of the endometrium: a clinicopathologic study of 19 cases. Gynecol Oncol. 1992, 46: 51-4. 10.1016/0090-8258(92)90195-O.
CAS
PubMed
Google Scholar
Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ: Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol. 1992, 16: 600-10.
CAS
PubMed
Google Scholar
Berman JJ, Albores-Saavedra J, Bostwick D, Delellis R, Eble J, Hamilton SR, Hruban RH, Mutter GL, Page D, Rohan T, Travis W, Henson DE: Precancer: a conceptual working definition – results of a Consensus Conference. Cancer Detect Prev. 2006, 30: 387-94. 10.1016/j.cdp.2006.09.002.
PubMed
Google Scholar
Cullen TS: Cancer of the Uterus: its pathology, symptomatology, diagnosis and treatment. 1900, New York: Appleton & Co
Google Scholar
Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985, 56: 403-12. 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X.
CAS
PubMed
Google Scholar
Taylor HC: Endometrial hyperplasia and carcinoma of the body of the uterus. Am J Obstet Gynecol. 1932, 23: 309-332.
Google Scholar
Novak E, Yui E: Relation of endometrial hyperplasia to adenocarcinoma of the uterus. Am J Obstet Gynecol. 1936, 32: 674-698.
Google Scholar
Beutler HK, Dockerty MB, Randall LM: Precancerous lesions of the endometrium. Am J Obstet Gynecol. 1963, 86: 433-443.
CAS
PubMed
Google Scholar
Steiner GJ, Kistner RW, Craig JM: Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium – further observations. Metabolism. 1963, 14: 356-386. 10.1016/0026-0495(65)90024-7.
PubMed
Google Scholar
Ruffolo EH, Cavanagh D, Marsden DE: Glandular intraepithelial neoplasia (GIN) – a unifying concept of the precursors of endometrial adenocarcinoma. Aust N Z J Obstet Gynaecol. 1983, 23: 220-5. 10.1111/j.1479-828X.1983.tb00582.x.
CAS
PubMed
Google Scholar
Vellios F: Endometrial hyperplasias, precursors of endometrial carcinoma. Pathol Annu. 1972, 7: 201-229.
CAS
PubMed
Google Scholar
Speert H: The premalignant phase of endometrial carcinoma. Cancer. 1952, 5: 927-944. 10.1002/1097-0142(195209)5:5<927::AID-CNCR2820050509>3.0.CO;2-G.
CAS
PubMed
Google Scholar
Vellios F: Endometrial hyperplasia and carcinoma in situ. Gynecol Oncol. 1974, 2: 152-161. 10.1016/0090-8258(74)90006-7.
CAS
PubMed
Google Scholar
Gusberg SB: Precursors of corpus carcinoma. Estrogens and adenomatous hyperplasia. Am J Obstet Gynecol. 1947, 54: 905-927.
CAS
PubMed
Google Scholar
Campbell PE, Barter RA: The significance of atypical endometrial hyperplasia. J Obstet and Gynaecol Br Commonw. 1961, 68: 668-672.
CAS
Google Scholar
Gusberg SB, Kaplan AL: Precursors of corpus cancer. IV. Adenomatous hyperplasia as stage 0 carcinoma of the endometrium. Am J Obstet Gynecol. 1963, 87: 662-678.
CAS
PubMed
Google Scholar
Hertig AT, Sommers SC: Genesis of endometrial carcinoma. I. Study of prior biopsies. Cancer. 1949, 2: 964-971. 10.1002/1097-0142(194911)2:6<964::AID-CNCR2820020605>3.0.CO;2-B.
CAS
PubMed
Google Scholar
Gore H, Hertig AT: Carcinoma in situ of the endometrium. Am J Obstet Gynecol. 1966, 94: 134-155.
CAS
PubMed
Google Scholar
Fox H: The endometrial hyperplasias. Obstet Gynecol Annu. 1984, 13: 197-209.
CAS
PubMed
Google Scholar
Scully RE: Definition of precursors in gynecologic cancer. Cancer. 1981, 48 (2 Suppl): 531-7. 10.1002/1097-0142(19810715)48:1+<531::AID-CNCR2820481316>3.0.CO;2-C.
CAS
PubMed
Google Scholar
Welch WR, Scully RE: Precancerous lesions of the endometrium. Hum Pathol. 1977, 8: 503-12. 10.1016/S0046-8177(77)80111-1.
CAS
PubMed
Google Scholar
Norris HJ, Tavassoli FA, Kurman RJ: Endometrial hyperplasia and carcinoma. Diagnostic considerations. Am J Surg Pathol. 1983, 7: 839-47.
CAS
PubMed
Google Scholar
Colgan TJ, Norris HJ, Foster W, Kurman RJ, Fox CH: Predicting the outcome of endometrial hyperplasia by quantitative analysis of nuclear features using a linear discriminant function. Int J Gynecol Pathol. 1983, 1: 347-52.
CAS
PubMed
Google Scholar
Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982, 49: 2547-59. 10.1002/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0.
CAS
PubMed
Google Scholar
Tavassoli F, Kraus FT: Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol. 1978, 70: 770-9.
CAS
PubMed
Google Scholar
Hendrickson MR, Kempson RL: Surgical Pathology of the Uterine Corpus. 1980, Philadelphia: WB Saunders Co.
Google Scholar
Hunter JE, Tritz DE, Howell MG, DePriest PD, Gallion HH, Andrews SJ, Buckley SB, Kryscio RJ, van Nagell JR: The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia. Gynecol Oncol. 1994, 55: 66-71. 10.1006/gyno.1994.1249.
CAS
PubMed
Google Scholar
Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, Pickartz H, Wells M: A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol. 1999, 23: 1102-8. 10.1097/00000478-199909000-00014.
CAS
PubMed
Google Scholar
Mutter GL, Baak JP, Crum CP, Richart RM, Ferenczy A, Faquin WC: Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol. 2000, 190: 462-9. 10.1002/(SICI)1096-9896(200003)190:4<462::AID-PATH590>3.0.CO;2-D.
CAS
PubMed
Google Scholar
Mutter GL: Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000, 76: 287-90. 10.1006/gyno.1999.5580.
CAS
PubMed
Google Scholar
Hecht JL, Mutter GL: Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006, 24: 4783-91. 10.1200/JCO.2006.06.7173.
CAS
PubMed
Google Scholar
Mutter GL: Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol. 2000, 19: 301-9. 10.1097/00004347-200010000-00002.
CAS
PubMed
Google Scholar
Mutter GL: Diagnosis of premalignant endometrial disease. J Clin Pathol. 2002, 55: 326-31.
PubMed Central
CAS
PubMed
Google Scholar
Mutter GL, Zaino RJ, Baak JP, Bentley RC, Robboy SJ: Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol. 2007, 26: 103-14. 10.1097/PGP.0b013e31802e4696.
PubMed
Google Scholar
Baak JP, Mutter GL: EIN and WHO94. J Clin Pathol. 2005, 58: 1-6. 10.1136/jcp.2004.021071.
PubMed Central
CAS
PubMed
Google Scholar
Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ: Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995, 26: 1260-7. 10.1016/0046-8177(95)90203-1.
CAS
PubMed
Google Scholar
Spiegel GW: Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol. 1995, 19: 417-32.
CAS
PubMed
Google Scholar
Carcangiu ML, Tan LK, Chambers JT: Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol. 1997, 21: 1507-14. 10.1097/00000478-199712000-00015.
CAS
PubMed
Google Scholar
Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L: p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997, 150: 177-85.
PubMed Central
CAS
PubMed
Google Scholar
Zheng W, Khurana R, Farahmand S, Wang Y, Zhang ZF, Felix JC: p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol. 1998, 22: 1463-73. 10.1097/00000478-199812000-00003.
CAS
PubMed
Google Scholar
Kovalev S, Marchenko ND, Gugliotta BG, Chalas E, Chumas J, Moll UM: Loss of p53 function in uterine papillary serous carcinoma. Hum Pathol. 1998, 9: 613-9. 10.1016/S0046-8177(98)80012-9.
Google Scholar
Wheeler DT, Bell KA, Kurman RJ, Sherman ME: Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol. 2000, 24: A797-806. 10.1097/00000478-200006000-00004.
Google Scholar
Soslow RA, Pirog E, Isacson C: Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol. 2000, 24: 726-32. 10.1097/00000478-200005000-00012.
CAS
PubMed
Google Scholar
Baergen RN, Warren CD, Isacson C, Ellenson LH: Early uterine serous carcinoma: clonal origin of extrauterine disease. Int J Gynecol Pathol. 2001, 20: 214-9. 10.1097/00004347-200107000-00002.
CAS
PubMed
Google Scholar
McCluggage WG, Sumathi VP, McManus DT: Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. Hum Pathol. 2003, 34: 939-43. 10.1016/S0046-8177(03)00335-6.
CAS
PubMed
Google Scholar
Zheng W, Schwartz PE: Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol. 2005, 96: 579-82. 10.1016/j.ygyno.2004.12.045.
PubMed
Google Scholar
Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W: Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol. 2004, 12: 319-31. 10.1177/106689690401200405.
CAS
PubMed
Google Scholar
Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE: Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Mod Pathol. 2005, 18: 75-82. 10.1038/modpathol.3800271.
PubMed
Google Scholar
Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE: Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. Int J Surg Pathol. 2004, 12: 207-23. 10.1177/106689690401200302.
PubMed
Google Scholar
Marchesoni D, Driul L, Mozzanega B, Nardelli GB, Parenti A: Intraepithelial G3 adenocarcinoma of the endometrium after tamoxifen treatment. Arch Gynecol Obstet. 2005, 271: 62-5. 10.1007/s00404-004-0668-0.
CAS
PubMed
Google Scholar
Schwartz PE: The management of serous papillary uterine cancer. Curr Opin Oncol. 2006, 18: 494-9. 10.1097/01.cco.0000239890.36408.75.
PubMed
Google Scholar
Zheng W, Liang SX, Yi X, Ulukus EC, Davis JR, Chambers SK: Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma. Int J Gynecol Pathol. 2007, 26: 38-52. 10.1097/01.pgp.0000228138.56222.4e.
CAS
PubMed
Google Scholar
Idrees MT, Schlosshauer P, Li G, Burstein DE: GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma. Histopathology. 2006, 49: 75-81. 10.1111/j.1365-2559.2006.02447.x.
CAS
PubMed
Google Scholar
Friedrich M, Villena-Heinsen C, Mink D, Bonkhoff H, Schmidt W: Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer. Eur J Obstet Gynecol Reprod Biol. 1999, 82: 85-7. 10.1016/S0301-2115(98)00166-3.
CAS
PubMed
Google Scholar
Maksem JA, Lee SS: Endometrial intraepithelial carcinoma diagnosed by brush cytology and p53 immunostaining, and confirmed by hysterectomy. Diagn Cytopathol. 1998, 19: 284-7. 10.1002/(SICI)1097-0339(199810)19:4<284::AID-DC11>3.0.CO;2-J.
CAS
PubMed
Google Scholar
Moid F, Berezowski K: Pathologic quiz case: a 70-year-old woman with postmenopausal bleeding. Endometrial intraepithelial carcinoma, clear cell type. Arch Pathol Lab Med. 2004, 128: e157-8.
PubMed
Google Scholar
Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W: Precursors of endometrial clear cell carcinoma. Am J Surg Pathol. 2006, 30: 1519-30. 10.1097/01.pas.0000213296.88778.db.
PubMed
Google Scholar
Tavassoli FA, Devilee P, (Eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and female genital Organs. 2003, IARC Press. Lyon
Factor SM: Papillary adenocarcinoma of the endometrium with psammoma bodies. Arch Pathol. 1974, 98: 201-5.
CAS
PubMed
Google Scholar
Hameed K, Morgan DA: Papillary adenocarcinoma of endometrium with psammoma bodies. Histology and fine structure. Cancer. 1972, 29: 1326-35. 10.1002/1097-0142(197205)29:5<1326::AID-CNCR2820290530>3.0.CO;2-X.
CAS
PubMed
Google Scholar
Karpas CM, Bridge MF: Endometrial adenocarcinoma with psammomatous bodies. Am J Obstet Gynecol. 1963, 87: 935-41.
CAS
PubMed
Google Scholar
LiVolsi VA: Adenocarcinoma of the endometrium with psammoma bodies. Obstet Gynecol. 1977, 50: 725-8.
CAS
PubMed
Google Scholar
Cefis F, Carinelli SG, Marzi MM, Senzani F: Endometrial adenocarcinoma with psammoma bodies. Tumori. 1979, 65: 1979359-62.
Google Scholar
Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R: Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982, 6: 93-108.
CAS
PubMed
Google Scholar
Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML: Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003, 90: 181-5. 10.1016/S0090-8258(03)00195-1.
PubMed
Google Scholar
Gehrig PA, Groben PA, Fowler WC, Walton LA, Van Le L: Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol. 2001, 97: 153-7. 10.1016/S0029-7844(00)01096-6.
CAS
PubMed
Google Scholar
Clement PB, Young RH: Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2004, 11: 117-42. 10.1097/00125480-200405000-00001.
PubMed
Google Scholar
Jia L, Liu Y, Yi X, Miron A, Crum CP, Kong B, Zheng W: Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation:A Genetic Evidence Supporting its Precancer Nature for Endometrial Serous Carcinoma. Clin Cancer Res.
Yi X, Zheng W: Endometrial glandular dysplasia and endometrial intraepithelial neoplasia. Curr Opin Obstet Gynecol. 2008, 20: 20-25.
PubMed
Google Scholar
Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Dressler K, Jiang Z: The Oncofetal Protein IMP3: A Novel Biomarker for Endometrial Serous Carcinoma. Am J Surg Pathol. 2008, 32: 304-315.
PubMed
Google Scholar
Giri PG, Schneider V, Belgrad R: Clear cell carcinoma of the endometrium: an uncommon entity with a favorable prognosis. Int J Radiat Oncol Biol Phys. 1981, 7: 1383-7.
CAS
PubMed
Google Scholar
Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer. 1982, 49: 1511-23. 10.1002/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6.
CAS
PubMed
Google Scholar
Abeler VM, Kjorstad KE: Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases. Gynecol Oncol. 1991, 40: 207-17. 10.1016/0090-8258(90)90279-T.
CAS
PubMed
Google Scholar
Kurman RJ, Scully RE: Clear cell carcinoma of the endometrium: an analysis of 21 cases. Cancer. 1976, 37: 872-82. 10.1002/1097-0142(197602)37:2<872::AID-CNCR2820370236>3.0.CO;2-L.
CAS
PubMed
Google Scholar
Silverberg SG, De Giorgi LS: Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings. Cancer. 1973, 31: 1127-40. 10.1002/1097-0142(197305)31:5<1127::AID-CNCR2820310514>3.0.CO;2-E.
CAS
PubMed
Google Scholar
Webb GA, Lagios MD: Clear cell carcinoma of the endometrium. Am J Obstet Gynecol. 1987, 156: 1486-91.
CAS
PubMed
Google Scholar
Kanbour-Shakir A, Tobon H: Primary clear cell carcinoma of the endometrium: a clinicopathologic study of 20 cases. Int J Gynecol Pathol. 1991, 10: 67-78.
CAS
PubMed
Google Scholar
Carcangiu ML, Chambers JT: Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol. 1995, 14: 30-8.
CAS
PubMed
Google Scholar
Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC: Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 2003, 63: 6-11.
CAS
PubMed
Google Scholar
Hasumi K, Ehrmann RL: Clear cell carcinoma of the uterine endocervix with an in situ component. Cancer. 1978, 42: 2435-8. 10.1002/1097-0142(197811)42:5<2435::AID-CNCR2820420545>3.0.CO;2-S.
CAS
PubMed
Google Scholar
Parker JC, Van Nagell JR, Harralson JD: The mesonephroid (hypernephroid) carcinomatous pattern – a rare variant of primary endocervical adenocarcinoma. Cancer. 1973, 32: 259-65. 10.1002/1097-0142(197307)32:1<259::AID-CNCR2820320138>3.0.CO;2-B.
PubMed
Google Scholar
Roth LM, Hornback NB: Clear-cell adenocarcinoma of the cervix in young women. Cancer. 1974, 34: 1761-8. 10.1002/1097-0142(197411)34:5<1761::AID-CNCR2820340526>3.0.CO;2-#.
CAS
PubMed
Google Scholar